z-logo
open-access-imgOpen Access
Disease management programs in the USA and Europe are comparable (yet?) different
Author(s) -
Guus Schrijvers
Publication year - 2006
Publication title -
international journal of integrated care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.083
H-Index - 32
ISSN - 1568-4156
DOI - 10.5334/ijic.154
Subject(s) - disease management , disease , business , medicine , process management , pathology , parkinson's disease
I recently attended the Third Colloqium 2006 of the Disease Management Association of America (DMAA) in Philadelphia. Over three days, more than 300 researchers, health care providers and policy makers followed nearly eighty speakers on many aspects of Disease Management Programs (DMPs). I was the only visitor from Europe. Being there I had feelings of coming home: DMPs are in some aspects comparable with those in Europe. I had also the sensation that I had arrived on another planet: DMPs are in other aspects totally different. Based on the experiences in Philadelphia, I have made a comparison between the USA and Europe w1x. This is, of course, only a comparison based on a three-day congress visit.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom